Organisatie
Immunologie & Infectie
Sub-organisatie(s)
1 - 1 van 1
Huidige onderzoekers
1 - 10 of 105 results
- Philippe ALLIET (Lid)
- Ana Laura ANE KOURI (Lid)
- Paulien BAETEN (Lid)
- Bo BATENS (Lid)
- Lien BECKERS (Lid)
- Jeroen BOGIE (Lid)
- Laura BOLKAERTS (Lid)
- Bieke BROUX (Lid)
- Thalissa CAERS (Lid)
- Alessio CARDILLI (Lid)
Projecten
1 - 2 of 2
- Chronische inflammatie en bloed-hersenbarrière verstoring in neurodegeneratieVanaf1 sep 2021 → HedenFinanciering: BOF - tenure track
- Onderzoek in translationele immunomodulatie.Vanaf1 nov 2020 → HedenFinanciering: BOF - ZAP BOF mandaten
Publicaties
1 - 10 van 395
- PREVALENCE OF NAFLD AND ACCURACY OF NITS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME(2023)
Auteurs: Wouter ROBAEYS, Leen HEYENS, Nathalie Dhont, Geert VERSWIJVEL, Ger H. Koek, Geert ROBAEYS, Struyve Mathieu, Joris PENDERS, Sven Francque
Pagina's: S1032 - S1033 - Fertility preservation counselling for women with endometriosis: a European online survey(2023)
Auteurs: Nicole Saenger, Marco Menabrito, Attilio Di Spiezo Sardo, Josep Estadella, Jasper VERGUTS
Pagina's: 73 - 85 - Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancer(2023)
Auteurs: H. C. Donker, Kristof CUPPENS, Guy FROYEN, H. J. M. Groen, T. J. N. Hiltermann, Brigitte MAES, E. Schuuring, P. -J. Volders, G. A. Lunter, B. van Es
- 1037P Tumour mutational burden and HLA diversity by TruSight oncology 500 (TSO500) next generation sequencing panel and clinical outcome in non-small cell lung cancer(2020)
Auteurs: Kristof CUPPENS, Guy FROYEN, B. Cruys, Ellen GEERDENS, S. Zhang, B. Zhang, L. Decoster, Michiel THOMEER, Brigitte MAES
Pagina's: S713 - S714 - Large-scale benchmarking of circRNA detection tools reveals large differences in sensitivity but not in precision(2023)
Auteurs: Marieke Vromman, Jasper Anckaert, Stefania Bortoluzzi, Alessia Buratin, Chia-Ying Chen, Qinjie Chu, Trees-Juen Chuang, Roozbeh Dehghannasiri, Christoph Dieterich, Xin Dong, et al.
Pagina's: 1159 - 1169 - Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disorders(2021)
Auteurs: R Houghton, Joop VAN DEN BERGH, K Law, YT Liu, F de Vries
Pagina's: 1800 - 1814 - Multicenter study of automated systems for colistin susceptibility testing(2021)
Auteurs: Ahalieyah Anantharajah, Youri Glupczynski, Martin Hoebeke, Pierre Bogaerts, Philippe Declercq, Olivier Denis, Julie Descy, Katelijne Floré, Koen MAGERMAN, Hector Rodriguez-Villalobos, et al.
Pagina's: 575 - 579 - Correction to: Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a etrospective cohort study(2020)
Auteurs: Karlijn van Halem, Robin BRUYNDONCKX, Jeroen VAN DER HILST, Janneke COX, Paulien Driesen, Matthias Opsomer, Eveline Van Steenkiste, Bjorn STESSEL, Jasperina Dubois, Peter MESSIAEN
- Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group(2022)
Auteurs: I Vergote, E Van Nieuwenhuysen, S De Waele, C Vulsteke, C Lamot, H Van den Bulck, Nele CLAES, MP Graas, Guy DEBROCK, I Spoormans, et al.
Pagina's: 753 - 760 - Referral of Patients with Non-alcoholic Fatty Liver Disease with Significant Fibrosis from Primary Care to Secondary Care in Belgium(2021)
Auteurs: Leen HEYENS, Dana BUSSCHOTS, Judith Wellens, Marlies Devos, Luc Present, Birgitte Schoenmakers, Kitty De Munck, Eva Rubens, Katrien Joris, Roy REMMEN, et al.
Pagina's: 30 - 31